BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7251063)

  • 1. Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.
    Taylor G; Howard CJ
    Immunology; 1981 Jul; 43(3):519-25. PubMed ID: 7251063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice.
    Taylor G; Howard CJ; Gourlay RN
    Infect Immun; 1977 May; 16(2):422-31. PubMed ID: 558962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Mycoplasma pulmonis with mouse peritoneal macrophages and polymorphonuclear leucocytes.
    Taylor G; Howard CJ
    J Med Microbiol; 1980 Feb; 13(1):19-30. PubMed ID: 7359575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin class- and subclass-specific responses to Mycoplasma pulmonis in sera and secretions of naturally infected Sprague-Dawley female rats.
    Brown MB; Reyes L
    Infect Immun; 1991 Jun; 59(6):2181-5. PubMed ID: 2037378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of mycoplasmas and phagocytes.
    Howard CJ; Taylor G
    Yale J Biol Med; 1983; 56(5-6):643-8. PubMed ID: 6236619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
    Rose FV; Cebra JJ
    Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
    Davis JK; Davidson M; Schoeb TR
    Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro.
    Davis JK; Delozier KM; Asa DK; Minion FC; Cassell GH
    Infect Immun; 1980 Aug; 29(2):590-9. PubMed ID: 7216428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class-specific antibody responses to Mycoplasma pulmonis in sera and lungs of infected and vaccinated mice.
    Taylor G; Howard CJ
    Infect Immun; 1980 Sep; 29(3):1160-8. PubMed ID: 7429631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies to Mycoplasma pulmonis by an enzyme-linked immunosorbent assay.
    Horowitz SA; Cassell GH
    Infect Immun; 1978 Oct; 22(1):161-70. PubMed ID: 365742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.
    Cartner SC; Simecka JW; Lindsey JR; Cassell GH; Davis JK
    Infect Immun; 1995 Oct; 63(10):4138-42. PubMed ID: 7558330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice.
    Denny FW; Taylor-Robinson D; Allison AC
    J Med Microbiol; 1972 Aug; 5(3):327-36. PubMed ID: 4560750
    [No Abstract]   [Full Text] [Related]  

  • 13. Respiratory disease in a colony of rats. II. Isolation of Mycoplasma pulmonis from the natural disease, and the experimental disease induced with a cloned culture of this organism.
    Whittlestone P; Lemcke RM; Olds RJ
    J Hyg (Lond); 1972 Sep; 70(3):387-407. PubMed ID: 4506989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility to Mycoplasma pulmonis intranasal infection in X-linked immunodeficient (xid), severe combined immunodeficient (scid), and immunocompetent mice.
    Sandstedt K; Berglöf A; Feinstein R; Bölske G; Evengård B; Smith CI
    Clin Exp Immunol; 1997 Jun; 108(3):490-6. PubMed ID: 9182897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase micro-radioimmunoassay to measure immunoglobulin class-specific antibody to Mycoplasma pulmonis.
    Taylor G
    Infect Immun; 1979 Jun; 24(3):701-6. PubMed ID: 468375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
    Hodge LM; Simecka JW
    J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pneumonia induced in mice with Mycoplasma pulmonis on resistance to subsequent bacterial infection and the effect of a respiratory infection with Sendai virus on the resistance of mice to Mycoplasma pulmonis.
    Howard CJ; Stott EJ; Taylor G
    J Gen Microbiol; 1978 Nov; 109(1):79-87. PubMed ID: 215702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice.
    Taylor G; Taylor-Robinson D
    Immunology; 1976 May; 30(5):611-8. PubMed ID: 1278933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.
    Taylor G; Taylor-Robinson D
    Ann Rheum Dis; 1977 Jun; 36(3):232-8. PubMed ID: 879860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aging on antibody avidity to Mycoplasma pulmonis.
    Steffen MJ; Ebersole JL
    Mech Ageing Dev; 1995 Mar; 78(2):123-44. PubMed ID: 7596194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.